Deleting ghrelin receptor, but not ghrelin, turns up fat-burning thermostat

December 13, 2010

Deleting the receptor, not the protein ghrelin itself, turns up the body's fat-burning thermostat, giving aging mice an exothermic boost toward a svelte physique, researchers reported at the American Society of Cell Biology's 50th Annual Meeting in Philadelphia.

The protein's receptor, growth hormone secretagogue receptor (GHS-R), might make a better target than ghrelin for treating obesity, according to Yuxiang Sun, M.D., Ph.D., of the Baylor College of Medicine in Houston, TX.

Sun said that experimentally deleting the receptor from the body cells of laboratory mice prevented obesity by diminishing white adipose tissues and activating brown adipose tissue, thereby increasing heat production.

The new finding that ghrelin may not be as critical to energy expenditure as its receptor, GHS-R, came from research on body temperature regulation at Baylor, Sun explained. GHS-R acts as the "lock" for the "key-like" ligand ghrelin to dock; GHS-R subsequently activates down-stream metabolic signal pathways.

With colleagues from Baylor and other institutions, Sun created two sets of genetically modified mice: one was null for ghrelin, while the other group was null for GHS-R. When challenged by cold and fasting, only the mice without GHS-R maintained a normal body temperature.

Intrigued by this finding, the researchers generated two additional cohorts of these knockout mice -- a young group 3 to 4 months old and an older group 10 to 12 months old −− to determine whether obesity and physical activity levels were influenced by age.

The scientists compiled a complete energy metabolic profile for each mouse, charting the animal's food intake against energy output. The energy profiles revealed that neither food intake nor activity levels differed in the gene-deleted mice compared to normal mice, regardless of age. But the GHS-R null mice were thinner because they were more exothermic.

Like aging humans, aging mice gain weight by accumulating fat. In contrast, the older GHS-R null mice maintained a lean physiological profile with lower circulating lipids and exhibited the high-energy expenditure levels that characterized the young mice.

These older GHS-R null mice weren't more active. However, without extra effort, they burned as heat more calories and fat. Meanwhile the older ghrelin-deleted mice followed the pattern of obesity in normal again mice: growing older and fatter.

In the ghrelin-deleted and the GHS-R deleted mice, the researchers then compared levels of UCP1, an "uncoupling protein" known as a hallmark regulator of thermogenic functioning in brown fat.

Consistently UCP1 was significantly higher in the brown fat of GHS-R deleted mice than in the ghrelin-deleted mice. The brown fat of the older GHS-R deleted mice included a higher proportion of smaller fat droplets, an indication of enhanced heat production, said Sun.

The 1999 discovery of ghrelin's role in appetite and energy balance ignited hopes that it was the body's long-sought hunger thermostat. Ghrelin remains the only circulating peptide known to stimulate appetite and promote obesity in both humans and rodents, but it also plays other roles in regulating growth and metabolism.

"All this shows the complexity of ghrelin and its signaling pathway, and suggests the existence of additional unidentified regulators mediating the effect of ghrelin and/or GHS-R," said Sun.
-end-
FOR MORE INFORMATION:

ASCB contacts:

Cathy Yarbrough
sciencematter@yahoo.com
858-243-1814 (cell)
215-418-5306 (Dec. 11-16)

John Fleischman
jfleischman@ascb.org
513-929-4635 (before Dec. 11)
513-706-0212 (cell)

Baylor College of Medicine contacts:

Yuxiang Sun, M.D, Ph.D.
713-798-7167
yuxiangs@bcm.edu

Dipali Pathak
Communications Specialist
713-798-4712
832-605-2987 (cell)

Sun will present, "Ablations of ghrelin and ghrelin receptor exhibit differential metabolic phenotype and differential thermogenic gene expression in brown adipose tissue," Monday, Dec. 13, 2010, 1 -2:30 p.m., in Aging and Aging-Related Diseases, Exhibit Halls A/B/C, Program 1717,Board B1240.

Co-authors: Xiaojun Ma, Ligen Lin, Marta Fiorotto, Yuxiang Sun, Baylor College of Medicine Houston, TX; Guijun Qin, Internal Medicine, First Affiliated Hospital of Zhengzhou, China; and Vishwa D. Dixit, Pennington Biomedical Research Center, Louisiana Sate University System, Baton Rouge, LA

Funding: This study was supported by USDA/ARS CRIS fund, ARS 6250-51000-055 and NIH/NIA grant 1R03AG029641-01.

American Society for Cell Biology

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.